| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | hemi-methylated DNA-binding | 2.86e-06 | 3 | 20 | 2 | GO:0044729 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 1.66e-05 | 1271 | 20 | 8 | GO:0000987 | |
| GeneOntologyMolecularFunction | double-stranded methylated DNA binding | 2.00e-05 | 7 | 20 | 2 | GO:0010385 | |
| GeneOntologyMolecularFunction | MDM2/MDM4 family protein binding | 7.39e-05 | 13 | 20 | 2 | GO:0097371 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 1.35e-04 | 1244 | 20 | 7 | GO:0000978 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.86e-04 | 560 | 20 | 5 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.96e-04 | 566 | 20 | 5 | GO:0001216 | |
| GeneOntologyMolecularFunction | WW domain binding | 2.82e-04 | 25 | 20 | 2 | GO:0050699 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 2.97e-04 | 1412 | 20 | 7 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3.64e-04 | 1459 | 20 | 7 | GO:0000977 | |
| GeneOntologyMolecularFunction | transcription factor binding | 7.28e-04 | 753 | 20 | 5 | GO:0008134 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 1.58e-03 | 59 | 20 | 2 | GO:0001222 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 2.39e-03 | 582 | 20 | 4 | GO:0140297 | |
| GeneOntologyMolecularFunction | p53 binding | 2.67e-03 | 77 | 20 | 2 | GO:0002039 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 3.09e-03 | 83 | 20 | 2 | GO:1990841 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 7.92e-03 | 417 | 20 | 3 | GO:0061629 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 8.54e-03 | 140 | 20 | 2 | GO:0001221 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 1.01e-02 | 875 | 20 | 4 | GO:0019904 | |
| GeneOntologyBiologicalProcess | regulation of metanephric glomerular mesangial cell proliferation | 8.93e-07 | 2 | 20 | 2 | GO:0072301 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 3.87e-06 | 741 | 20 | 7 | GO:0006338 | |
| GeneOntologyBiologicalProcess | metanephric glomerular mesangium development | 5.35e-06 | 4 | 20 | 2 | GO:0072223 | |
| GeneOntologyBiologicalProcess | metanephric glomerular mesangial cell proliferation involved in metanephros development | 5.35e-06 | 4 | 20 | 2 | GO:0072262 | |
| GeneOntologyBiologicalProcess | negative regulation of intracellular steroid hormone receptor signaling pathway | 7.53e-06 | 40 | 20 | 3 | GO:0033144 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 8.07e-06 | 136 | 20 | 4 | GO:0030518 | |
| GeneOntologyBiologicalProcess | chromatin organization | 1.34e-05 | 896 | 20 | 7 | GO:0006325 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 1.35e-05 | 155 | 20 | 4 | GO:0043401 | |
| GeneOntologyBiologicalProcess | estrogen receptor signaling pathway | 2.21e-05 | 57 | 20 | 3 | GO:0030520 | |
| GeneOntologyBiologicalProcess | metanephric glomerulus vasculature development | 2.49e-05 | 8 | 20 | 2 | GO:0072239 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 2.65e-05 | 1399 | 20 | 8 | GO:0045892 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 2.72e-05 | 999 | 20 | 7 | GO:0071824 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 2.84e-05 | 1413 | 20 | 8 | GO:1902679 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 3.83e-05 | 202 | 20 | 4 | GO:0141193 | |
| GeneOntologyBiologicalProcess | cell proliferation involved in metanephros development | 4.89e-05 | 11 | 20 | 2 | GO:0072203 | |
| GeneOntologyBiologicalProcess | animal organ formation | 5.66e-05 | 78 | 20 | 3 | GO:0048645 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 7.36e-05 | 239 | 20 | 4 | GO:0071383 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 7.85e-05 | 87 | 20 | 3 | GO:0033143 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 7.98e-05 | 244 | 20 | 4 | GO:0009755 | |
| GeneOntologyBiologicalProcess | regulation of glomerular mesangial cell proliferation | 8.07e-05 | 14 | 20 | 2 | GO:0072124 | |
| GeneOntologyBiologicalProcess | glomerular mesangial cell proliferation | 9.31e-05 | 15 | 20 | 2 | GO:0072110 | |
| GeneOntologyBiologicalProcess | negative regulation of intracellular estrogen receptor signaling pathway | 9.31e-05 | 15 | 20 | 2 | GO:0033147 | |
| GeneOntologyBiologicalProcess | metanephric glomerulus development | 9.31e-05 | 15 | 20 | 2 | GO:0072224 | |
| GeneOntologyBiologicalProcess | metanephros development | 1.02e-04 | 95 | 20 | 3 | GO:0001656 | |
| GeneOntologyBiologicalProcess | glomerular mesangium development | 1.35e-04 | 18 | 20 | 2 | GO:0072109 | |
| GeneOntologyBiologicalProcess | regulation of cell proliferation involved in kidney development | 1.35e-04 | 18 | 20 | 2 | GO:1901722 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 2.30e-04 | 605 | 20 | 5 | GO:0071407 | |
| GeneOntologyBiologicalProcess | cell proliferation involved in kidney development | 2.64e-04 | 25 | 20 | 2 | GO:0072111 | |
| GeneOntologyBiologicalProcess | response to hormone | 3.44e-04 | 1042 | 20 | 6 | GO:0009725 | |
| GeneOntologyBiologicalProcess | metanephros morphogenesis | 3.57e-04 | 29 | 20 | 2 | GO:0003338 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 3.65e-04 | 1053 | 20 | 6 | GO:0000122 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature development | 3.82e-04 | 30 | 20 | 2 | GO:0072012 | |
| GeneOntologyBiologicalProcess | kidney development | 4.01e-04 | 372 | 20 | 4 | GO:0001822 | |
| GeneOntologyBiologicalProcess | kidney vasculature development | 4.08e-04 | 31 | 20 | 2 | GO:0061440 | |
| GeneOntologyBiologicalProcess | renal system vasculature development | 4.08e-04 | 31 | 20 | 2 | GO:0061437 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 4.39e-04 | 381 | 20 | 4 | GO:0048545 | |
| GeneOntologyBiologicalProcess | renal system development | 4.61e-04 | 386 | 20 | 4 | GO:0072001 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 5.35e-04 | 727 | 20 | 5 | GO:0032870 | |
| GeneOntologyBiologicalProcess | regulation of intracellular estrogen receptor signaling pathway | 5.52e-04 | 36 | 20 | 2 | GO:0033146 | |
| GeneOntologyBiologicalProcess | neuron apoptotic process | 5.95e-04 | 413 | 20 | 4 | GO:0051402 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 6.12e-04 | 416 | 20 | 4 | GO:0030522 | |
| GeneOntologyBiologicalProcess | metanephric nephron development | 6.15e-04 | 38 | 20 | 2 | GO:0072210 | |
| GeneOntologyBiologicalProcess | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 1.02e-03 | 49 | 20 | 2 | GO:0042771 | |
| GeneOntologyBiologicalProcess | genitalia development | 1.24e-03 | 54 | 20 | 2 | GO:0048806 | |
| GeneOntologyBiologicalProcess | digestive tract morphogenesis | 1.48e-03 | 59 | 20 | 2 | GO:0048546 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 1.58e-03 | 1390 | 20 | 6 | GO:0045944 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA transcription | 1.58e-03 | 61 | 20 | 2 | GO:1902895 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 1.82e-03 | 558 | 20 | 4 | GO:0060537 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA metabolic process | 2.25e-03 | 73 | 20 | 2 | GO:2000630 | |
| GeneOntologyBiologicalProcess | circadian regulation of gene expression | 2.38e-03 | 75 | 20 | 2 | GO:0032922 | |
| GeneOntologyBiologicalProcess | glomerulus development | 2.50e-03 | 77 | 20 | 2 | GO:0032835 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 2.65e-03 | 619 | 20 | 4 | GO:0002009 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 2.74e-03 | 1048 | 20 | 5 | GO:0014070 | |
| GeneOntologyBiologicalProcess | regulation of miRNA transcription | 2.90e-03 | 83 | 20 | 2 | GO:1902893 | |
| GeneOntologyBiologicalProcess | miRNA transcription | 2.97e-03 | 84 | 20 | 2 | GO:0061614 | |
| GeneOntologyBiologicalProcess | intrinsic apoptotic signaling pathway by p53 class mediator | 3.62e-03 | 93 | 20 | 2 | GO:0072332 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 3.68e-03 | 327 | 20 | 3 | GO:0048738 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 4.42e-03 | 349 | 20 | 3 | GO:0014706 | |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 4.42e-03 | 103 | 20 | 2 | GO:2000628 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic process | 4.52e-03 | 718 | 20 | 4 | GO:0043065 | |
| HumanPheno | Septate vagina | 7.59e-05 | 12 | 6 | 2 | HP:0001153 | |
| HumanPheno | Ectopic anus | 1.13e-04 | 93 | 6 | 3 | HP:0004397 | |
| HumanPheno | Abnormal clitoris morphology | 1.41e-04 | 100 | 6 | 3 | HP:0000056 | |
| HumanPheno | Vaginal atresia | 1.75e-04 | 18 | 6 | 2 | HP:0000148 | |
| HumanPheno | Genital tract atresia | 1.75e-04 | 18 | 6 | 2 | HP:0001827 | |
| HumanPheno | Central diabetes insipidus | 2.64e-04 | 22 | 6 | 2 | HP:0000863 | |
| HumanPheno | Ambiguous genitalia | 2.67e-04 | 124 | 6 | 3 | HP:0000062 | |
| HumanPheno | Abnormal vagina morphology | 2.93e-04 | 128 | 6 | 3 | HP:0000142 | |
| HumanPheno | Urethral atresia | 3.15e-04 | 24 | 6 | 2 | HP:0000068 | |
| HumanPheno | Urinary tract atresia | 3.15e-04 | 24 | 6 | 2 | HP:0000809 | |
| HumanPheno | Choanal atresia or stenosis | 3.36e-04 | 134 | 6 | 3 | HP:0000416 | |
| HumanPheno | Abnormal choanae morphology | 3.36e-04 | 134 | 6 | 3 | HP:0000415 | |
| HumanPheno | Abnormal cortical gyration | 4.39e-04 | 388 | 6 | 4 | HP:0002536 | |
| HumanPheno | Hypoplasia of penis | 5.34e-04 | 408 | 6 | 4 | HP:0008736 | |
| HumanPheno | Abnormal female external genitalia morphology | 5.78e-04 | 161 | 6 | 3 | HP:0000055 | |
| HumanPheno | Absent eyelashes | 6.01e-04 | 33 | 6 | 2 | HP:0000561 | |
| HumanPheno | Anal stenosis | 6.38e-04 | 34 | 6 | 2 | HP:0002025 | |
| HumanPheno | Absent facial hair | 7.98e-04 | 38 | 6 | 2 | HP:0002550 | |
| HumanPheno | Streak ovary | 8.40e-04 | 39 | 6 | 2 | HP:0010464 | |
| HumanPheno | Cleft upper lip | 8.42e-04 | 183 | 6 | 3 | HP:0000204 | |
| HumanPheno | Abnormality of neuronal migration | 9.77e-04 | 477 | 6 | 4 | HP:0002269 | |
| HumanPheno | Heterotopias/abnormal migration | 9.77e-04 | 477 | 6 | 4 | HP:0007317 | |
| HumanPheno | Aniridia | 1.12e-03 | 45 | 6 | 2 | HP:0000526 | |
| HumanPheno | Sparse axillary hair | 1.17e-03 | 46 | 6 | 2 | HP:0002215 | |
| HumanPheno | Abnormal lung lobation | 1.22e-03 | 47 | 6 | 2 | HP:0002101 | |
| HumanPheno | Corneal erosion | 1.27e-03 | 48 | 6 | 2 | HP:0200020 | |
| HumanPheno | Hypoplastic male external genitalia | 1.30e-03 | 514 | 6 | 4 | HP:0000050 | |
| HumanPheno | Abnormal lacrimal duct morphology | 1.38e-03 | 50 | 6 | 2 | HP:0011481 | |
| HumanPheno | Sparse pubic hair | 1.44e-03 | 51 | 6 | 2 | HP:0002225 | |
| HumanPheno | Bicornuate uterus | 1.49e-03 | 52 | 6 | 2 | HP:0000813 | |
| HumanPheno | Abnormal anus morphology | 1.52e-03 | 224 | 6 | 3 | HP:0034915 | |
| HumanPheno | Decreased serum estradiol | 1.61e-03 | 54 | 6 | 2 | HP:0008214 | |
| HumanPheno | External genital hypoplasia | 1.62e-03 | 544 | 6 | 4 | HP:0003241 | |
| HumanPheno | Abnormal posterior pituitary morphogenesis | 1.67e-03 | 55 | 6 | 2 | HP:0011751 | |
| HumanPheno | Elevated circulating follicle stimulating hormone level | 1.67e-03 | 55 | 6 | 2 | HP:0008232 | |
| HumanPheno | Abnormality of the axillary hair | 1.73e-03 | 56 | 6 | 2 | HP:0100134 | |
| HumanPheno | Abnormality of the pubic hair | 1.79e-03 | 57 | 6 | 2 | HP:0100133 | |
| HumanPheno | Atresia of the external auditory canal | 1.86e-03 | 58 | 6 | 2 | HP:0000413 | |
| HumanPheno | Abnormal thymus morphology | 1.86e-03 | 58 | 6 | 2 | HP:0000777 | |
| HumanPheno | Cleft lip | 1.86e-03 | 240 | 6 | 3 | HP:0410030 | |
| HumanPheno | Abnormality of the anus | 2.00e-03 | 246 | 6 | 3 | HP:0004378 | |
| HumanPheno | Absent hair | 2.05e-03 | 61 | 6 | 2 | HP:0002298 | |
| HumanPheno | Abnormal serum estradiol | 2.12e-03 | 62 | 6 | 2 | HP:0025133 | |
| HumanPheno | Abnormal circulating estrogen level | 2.19e-03 | 63 | 6 | 2 | HP:0025132 | |
| HumanPheno | Abnormal number of incisors | 2.19e-03 | 63 | 6 | 2 | HP:0011064 | |
| HumanPheno | Abnormality of the uterus | 2.24e-03 | 256 | 6 | 3 | HP:0000130 | |
| HumanPheno | Diabetes insipidus | 2.26e-03 | 64 | 6 | 2 | HP:0000873 | |
| HumanPheno | Anteriorly placed anus | 2.54e-03 | 68 | 6 | 2 | HP:0001545 | |
| HumanPheno | Renal duplication | 2.62e-03 | 69 | 6 | 2 | HP:0000075 | |
| HumanPheno | Abdominal organ duplication | 2.62e-03 | 69 | 6 | 2 | HP:0005217 | |
| HumanPheno | Clitoral hypertrophy | 2.69e-03 | 70 | 6 | 2 | HP:0008665 | |
| HumanPheno | Abnormal size of the clitoris | 2.69e-03 | 70 | 6 | 2 | HP:0040252 | |
| HumanPheno | Increased size of the clitoris | 2.69e-03 | 70 | 6 | 2 | HP:0040253 | |
| MousePheno | abnormal lung morphology | 6.36e-06 | 767 | 15 | 7 | MP:0001175 | |
| MousePheno | increased hemolymphoid system tumor incidence | 4.10e-05 | 191 | 15 | 4 | MP:0010296 | |
| MousePheno | abnormal respiratory system morphology | 4.31e-05 | 1027 | 15 | 7 | MP:0002132 | |
| MousePheno | absent eyelids | 7.05e-05 | 12 | 15 | 2 | MP:0001341 | |
| MousePheno | absent ovary | 8.33e-05 | 13 | 15 | 2 | MP:0003578 | |
| MousePheno | myocardium hypoplasia | 9.70e-05 | 86 | 15 | 3 | MP:0010500 | |
| MousePheno | increased metanephric mesenchyme apoptosis | 9.71e-05 | 14 | 15 | 2 | MP:0011386 | |
| MousePheno | abnormal ovulation | 1.39e-04 | 97 | 15 | 3 | MP:0001928 | |
| MousePheno | abnormal blood circulation | 1.50e-04 | 845 | 15 | 6 | MP:0002128 | |
| MousePheno | increased sarcoma incidence | 1.61e-04 | 102 | 15 | 3 | MP:0002032 | |
| MousePheno | agonadal | 1.63e-04 | 18 | 15 | 2 | MP:0005644 | |
| MousePheno | absent sex gland | 1.63e-04 | 18 | 15 | 2 | MP:0000654 | |
| MousePheno | heart hypoplasia | 1.66e-04 | 103 | 15 | 3 | MP:0002740 | |
| MousePheno | abnormal skin development | 1.82e-04 | 19 | 15 | 2 | MP:0003941 | |
| MousePheno | abnormal metanephros morphology | 2.23e-04 | 21 | 15 | 2 | MP:0011364 | |
| MousePheno | thick dermal layer | 2.45e-04 | 22 | 15 | 2 | MP:0001245 | |
| MousePheno | blistering | 2.93e-04 | 24 | 15 | 2 | MP:0001208 | |
| MousePheno | small heart | 3.05e-04 | 321 | 15 | 4 | MP:0002188 | |
| MousePheno | abnormal metanephric mesenchyme morphology | 3.18e-04 | 25 | 15 | 2 | MP:0010984 | |
| MousePheno | abnormal glomerular capsule space morphology | 3.71e-04 | 27 | 15 | 2 | MP:0011499 | |
| MousePheno | abnormal kidney mesenchyme morphology | 4.00e-04 | 28 | 15 | 2 | MP:0010985 | |
| MousePheno | absent spleen | 4.29e-04 | 29 | 15 | 2 | MP:0000690 | |
| MousePheno | diaphragmatic hernia | 4.29e-04 | 29 | 15 | 2 | MP:0003924 | |
| MousePheno | hemorrhage | 4.80e-04 | 664 | 15 | 5 | MP:0001914 | |
| MousePheno | increased lung adenoma incidence | 5.57e-04 | 33 | 15 | 2 | MP:0002048 | |
| MousePheno | anovulation | 5.57e-04 | 33 | 15 | 2 | MP:0008869 | |
| MousePheno | abnormal lung adenoma incidence | 5.57e-04 | 33 | 15 | 2 | MP:0020190 | |
| MousePheno | increased classified tumor incidence | 5.84e-04 | 381 | 15 | 4 | MP:0010273 | |
| MousePheno | abnormal classified tumor incidence | 6.02e-04 | 384 | 15 | 4 | MP:0020188 | |
| MousePheno | internal hemorrhage | 6.20e-04 | 387 | 15 | 4 | MP:0001634 | |
| MousePheno | increased lymphoma incidence | 6.50e-04 | 164 | 15 | 3 | MP:0012431 | |
| MousePheno | increased organ/body region tumor incidence | 6.69e-04 | 395 | 15 | 4 | MP:0010274 | |
| MousePheno | abnormal organ/body region tumor incidence | 7.08e-04 | 401 | 15 | 4 | MP:0013152 | |
| MousePheno | increased osteoblast cell number | 7.39e-04 | 38 | 15 | 2 | MP:0004988 | |
| MousePheno | increased incidence of induced tumors | 7.60e-04 | 173 | 15 | 3 | MP:0002021 | |
| MousePheno | kidney cyst | 8.12e-04 | 177 | 15 | 3 | MP:0003675 | |
| MousePheno | absent estrous cycle | 9.91e-04 | 44 | 15 | 2 | MP:0009009 | |
| MousePheno | abnormal ovary morphology | 1.10e-03 | 451 | 15 | 4 | MP:0001126 | |
| MousePheno | abnormal glomerular capillary morphology | 1.13e-03 | 47 | 15 | 2 | MP:0011320 | |
| MousePheno | abnormal kidney capillary morphology | 1.18e-03 | 48 | 15 | 2 | MP:0011310 | |
| MousePheno | abnormal cranium morphology | 1.21e-03 | 813 | 15 | 5 | MP:0000438 | |
| MousePheno | abnormal fluid regulation | 1.30e-03 | 826 | 15 | 5 | MP:0001784 | |
| MousePheno | abnormal craniofacial bone morphology | 1.31e-03 | 827 | 15 | 5 | MP:0002116 | |
| MousePheno | abnormal female reproductive gland morphology | 1.33e-03 | 475 | 15 | 4 | MP:0013324 | |
| MousePheno | increased T cell derived lymphoma incidence | 1.43e-03 | 53 | 15 | 2 | MP:0002024 | |
| MousePheno | decreased aggression | 1.43e-03 | 53 | 15 | 2 | MP:0005656 | |
| MousePheno | increased thymus tumor incidence | 1.49e-03 | 54 | 15 | 2 | MP:0010365 | |
| MousePheno | abnormal female reproductive system physiology | 1.69e-03 | 876 | 15 | 5 | MP:0003699 | |
| MousePheno | myocardial trabeculae hypoplasia | 1.72e-03 | 58 | 15 | 2 | MP:0010503 | |
| MousePheno | increased malignant tumor incidence | 1.88e-03 | 237 | 15 | 3 | MP:0002018 | |
| MousePheno | abnormal head development | 1.96e-03 | 62 | 15 | 2 | MP:0012176 | |
| MousePheno | increased tumor incidence | 2.00e-03 | 530 | 15 | 4 | MP:0002020 | |
| MousePheno | abnormal ovarian follicle morphology | 2.07e-03 | 245 | 15 | 3 | MP:0001131 | |
| MousePheno | abnormal superovulation | 2.22e-03 | 66 | 15 | 2 | MP:0009648 | |
| MousePheno | glomerulosclerosis | 2.35e-03 | 68 | 15 | 2 | MP:0005264 | |
| MousePheno | abnormal incidence of induced tumors | 2.70e-03 | 269 | 15 | 3 | MP:0013151 | |
| MousePheno | abnormal prostate gland morphology | 2.70e-03 | 73 | 15 | 2 | MP:0001158 | |
| MousePheno | abnormal kidney vasculature morphology | 2.70e-03 | 73 | 15 | 2 | MP:0000530 | |
| MousePheno | premature aging | 2.70e-03 | 73 | 15 | 2 | MP:0003786 | |
| MousePheno | edema | 2.79e-03 | 581 | 15 | 4 | MP:0001785 | |
| MousePheno | abnormal osteoblast cell number | 3.00e-03 | 77 | 15 | 2 | MP:0004987 | |
| MousePheno | increased osteoclast cell number | 3.00e-03 | 77 | 15 | 2 | MP:0004984 | |
| MousePheno | abnormal diaphragm morphology | 3.08e-03 | 78 | 15 | 2 | MP:0002279 | |
| MousePheno | increased apoptosis | 3.15e-03 | 1008 | 15 | 5 | MP:0006042 | |
| Domain | P53 | 2.63e-06 | 3 | 18 | 2 | PF00870 | |
| Domain | P53_tetramer | 2.63e-06 | 3 | 18 | 2 | PF07710 | |
| Domain | p53_DNA-bd | 2.63e-06 | 3 | 18 | 2 | IPR011615 | |
| Domain | P53 | 2.63e-06 | 3 | 18 | 2 | PS00348 | |
| Domain | - | 2.63e-06 | 3 | 18 | 2 | 4.10.170.10 | |
| Domain | p53_tumour_suppressor | 2.63e-06 | 3 | 18 | 2 | IPR002117 | |
| Domain | p53_tetrameristn | 2.63e-06 | 3 | 18 | 2 | IPR010991 | |
| Domain | p53/RUNT-type_TF_DNA-bd | 1.31e-05 | 6 | 18 | 2 | IPR012346 | |
| Domain | - | 1.31e-05 | 6 | 18 | 2 | 2.60.40.720 | |
| Domain | SAM_2 | 7.74e-04 | 43 | 18 | 2 | PF07647 | |
| Domain | p53-like_TF_DNA-bd | 1.17e-03 | 53 | 18 | 2 | IPR008967 | |
| Domain | SAM | 3.20e-03 | 88 | 18 | 2 | SM00454 | |
| Domain | SAM_DOMAIN | 3.71e-03 | 95 | 18 | 2 | PS50105 | |
| Domain | SAM | 3.87e-03 | 97 | 18 | 2 | IPR001660 | |
| Domain | - | 4.60e-03 | 106 | 18 | 2 | 1.10.150.50 | |
| Domain | SAM/pointed | 5.58e-03 | 117 | 18 | 2 | IPR013761 | |
| Domain | - | 1.90e-02 | 222 | 18 | 2 | 1.25.10.10 | |
| Pathway | PID_P73PATHWAY | 1.19e-06 | 79 | 15 | 4 | M19 | |
| Pathway | REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA | 3.79e-05 | 9 | 15 | 2 | M26946 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DEATH_RECEPTORS_AND_LIGANDS | 6.93e-05 | 12 | 15 | 2 | M27631 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CASPASE_ACTIVATORS_AND_CASPASES | 6.93e-05 | 12 | 15 | 2 | M27630 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN | 9.55e-05 | 14 | 15 | 2 | M27629 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 9.55e-05 | 14 | 15 | 2 | MM15341 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 9.55e-05 | 14 | 15 | 2 | M27638 | |
| Pathway | WP_TP53_NETWORK | 1.79e-04 | 19 | 15 | 2 | M39368 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE | 1.99e-04 | 20 | 15 | 2 | M27628 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 4.52e-04 | 30 | 15 | 2 | M17814 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES | 9.74e-04 | 44 | 15 | 2 | M27499 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 1.52e-03 | 55 | 15 | 2 | M7455 | |
| Pathway | WP_MARKERS_OF_KIDNEY_CELL_LINEAGE | 1.75e-03 | 59 | 15 | 2 | M46460 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 1.81e-03 | 60 | 15 | 2 | M40048 | |
| Pubmed | Physical interaction between Wilms tumor 1 and p73 proteins modulates their functions. | 7.59e-10 | 4 | 21 | 3 | 10744705 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 2.41e-08 | 877 | 21 | 8 | 20211142 | |
| Pubmed | p63 and p73 expression in extrahepatic bile duct carcinoma and their clinical significance. | 3.47e-07 | 2 | 21 | 2 | 17385050 | |
| Pubmed | p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. | 3.47e-07 | 2 | 21 | 2 | 16413471 | |
| Pubmed | The role of p53 protein family in gastrointestinal malignancies. | 3.47e-07 | 2 | 21 | 2 | 16557273 | |
| Pubmed | Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma. | 3.47e-07 | 2 | 21 | 2 | 17018588 | |
| Pubmed | The 5th International p63/p73 Workshop: much more than just tumour suppression. | 3.47e-07 | 2 | 21 | 2 | 22240899 | |
| Pubmed | Mechanism of TAp73 inhibition by ΔNp63 and structural basis of p63/p73 hetero-tetramerization. | 3.47e-07 | 2 | 21 | 2 | 27716744 | |
| Pubmed | Conformational stability and activity of p73 require a second helix in the tetramerization domain. | 3.47e-07 | 2 | 21 | 2 | 19763140 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 23095717 | ||
| Pubmed | p73 and p63 regulate the expression of fibroblast growth factor receptor 3. | 3.47e-07 | 2 | 21 | 2 | 20298673 | |
| Pubmed | EGR1 regulates hepatic clock gene amplitude by activating Per1 transcription. | 3.47e-07 | 2 | 21 | 2 | 26471974 | |
| Pubmed | Wilms tumor protein recognizes 5-carboxylcytosine within a specific DNA sequence. | 3.47e-07 | 2 | 21 | 2 | 25258363 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 25929687 | ||
| Pubmed | Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus. | 3.47e-07 | 2 | 21 | 2 | 1662794 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 20081800 | ||
| Pubmed | Induction of mPer1 expression by GnRH in pituitary gonadotrope cells involves EGR-1. | 3.47e-07 | 2 | 21 | 2 | 19616057 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 33375680 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 15280445 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 10373484 | ||
| Pubmed | p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivo. | 3.47e-07 | 2 | 21 | 2 | 16007185 | |
| Pubmed | TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy. | 3.47e-07 | 2 | 21 | 2 | 24983500 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 1489725 | ||
| Pubmed | In situ expression of the early growth response gene-1 during murine nephrogenesis. | 3.47e-07 | 2 | 21 | 2 | 7609158 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 14654522 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 28350813 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 20644729 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 17446929 | ||
| Pubmed | Tissue-specific expression of p73 and p63 isoforms in human tissues. | 3.47e-07 | 2 | 21 | 2 | 34315849 | |
| Pubmed | p63 antagonizes p53 to promote the survival of embryonic neural precursor cells. | 3.47e-07 | 2 | 21 | 2 | 19458240 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 21293190 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 15359011 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 16181796 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 16831876 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 33672023 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 18289041 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 21127199 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 17716971 | ||
| Pubmed | Regulation and function of the p53-related proteins: same family, different rules. | 1.04e-06 | 3 | 21 | 2 | 10754563 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 16601753 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 11957139 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 22538442 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 10203277 | ||
| Pubmed | The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. | 1.04e-06 | 3 | 21 | 2 | 20485546 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 16363065 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 24809925 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 23243311 | ||
| Pubmed | p53, p63 and p73--solos, alliances and feuds among family members. | 1.04e-06 | 3 | 21 | 2 | 11825686 | |
| Pubmed | The dominant-negative interplay between p53, p63 and p73: A family affair. | 1.04e-06 | 3 | 21 | 2 | 27589690 | |
| Pubmed | ΔNp63 regulates select routes of reprogramming via multiple mechanisms. | 1.04e-06 | 3 | 21 | 2 | 24013722 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 19067769 | ||
| Pubmed | Interaction between TP63 and MDM2 genes and the risk of recurrent pregnancy loss. | 1.04e-06 | 3 | 21 | 2 | 25218545 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 21427767 | ||
| Pubmed | Physical interaction with Yes-associated protein enhances p73 transcriptional activity. | 1.04e-06 | 3 | 21 | 2 | 11278685 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 19119599 | ||
| Pubmed | p63 and p73 are not required for the development and p53-dependent apoptosis of T cells. | 1.04e-06 | 3 | 21 | 2 | 15261144 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 14757278 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 22075982 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 15837625 | ||
| Pubmed | Structural evolution of p53, p63, and p73: implication for heterotetramer formation. | 1.04e-06 | 3 | 21 | 2 | 19815500 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 16449968 | ||
| Pubmed | deltaEF1 repressor controls selectively p53 family members during differentiation. | 1.04e-06 | 3 | 21 | 2 | 16007124 | |
| Pubmed | Repression of Pax-2 by WT1 during normal kidney development. | 1.04e-06 | 3 | 21 | 2 | 7720589 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 24213852 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 27447112 | ||
| Pubmed | p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. | 1.04e-06 | 3 | 21 | 2 | 11932750 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 22496369 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 30099987 | ||
| Pubmed | How the TP53 family proteins TP63 and TP73 contribute to tumorigenesis: regulators and effectors. | 1.04e-06 | 3 | 21 | 2 | 24488880 | |
| Pubmed | A novel response element confers p63- and p73-specific activation of the WNT4 promoter. | 1.04e-06 | 3 | 21 | 2 | 16343436 | |
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 26652033 | ||
| Pubmed | A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells. | 1.04e-06 | 3 | 21 | 2 | 16990849 | |
| Pubmed | Differential expression of p53, p63 and p73 proteins in human buccal squamous-cell carcinomas. | 1.04e-06 | 3 | 21 | 2 | 12969350 | |
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 29107083 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 19747485 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 11238924 | ||
| Pubmed | Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. | 2.08e-06 | 4 | 21 | 2 | 15607981 | |
| Pubmed | Mutant p53 antagonizes p63/p73-mediated tumor suppression via Notch1. | 2.08e-06 | 4 | 21 | 2 | 31712410 | |
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 17336302 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 12954772 | ||
| Pubmed | E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis. | 2.08e-06 | 4 | 21 | 2 | 25146927 | |
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 29988075 | ||
| Pubmed | p73 and p63 protein stability: the way to regulate function? | 2.08e-06 | 4 | 21 | 2 | 14555234 | |
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 14729977 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 11925430 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 25417702 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 21933882 | ||
| Pubmed | IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo. | 2.08e-06 | 4 | 21 | 2 | 25409149 | |
| Pubmed | Thymine-DNA glycosylase interacts with and functions as a coactivator of p53 family proteins. | 2.08e-06 | 4 | 21 | 2 | 18951877 | |
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 18064689 | ||
| Pubmed | The transcriptional repressor hDaxx potentiates p53-dependent apoptosis. | 2.08e-06 | 4 | 21 | 2 | 15339933 | |
| Pubmed | The p53 family members have distinct roles during mammalian embryonic development. | 2.08e-06 | 4 | 21 | 2 | 28211873 | |
| Pubmed | Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73. | 3.47e-06 | 5 | 21 | 2 | 21088494 | |
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 27889317 | ||
| Pubmed | Molecular mechanism of mutant p53 stabilization: the role of HSP70 and MDM2. | 3.47e-06 | 5 | 21 | 2 | 23251530 | |
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 33823136 | ||
| Pubmed | p63 induces key target genes required for epidermal morphogenesis. | 3.47e-06 | 5 | 21 | 2 | 17360634 | |
| Pubmed | p53 family members in myogenic differentiation and rhabdomyosarcoma development. | 3.47e-06 | 5 | 21 | 2 | 17045206 | |
| Pubmed | Regulation of female reproduction by p53 and its family members. | 3.47e-06 | 5 | 21 | 2 | 21402718 | |
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 18275817 | ||
| Interaction | WT1 interactions | 1.06e-06 | 76 | 21 | 4 | int:WT1 | |
| Interaction | WWP1 interactions | 5.91e-06 | 260 | 21 | 5 | int:WWP1 | |
| Interaction | NPIPB13 interactions | 6.20e-06 | 4 | 21 | 2 | int:NPIPB13 | |
| Interaction | AGBL2 interactions | 3.71e-05 | 9 | 21 | 2 | int:AGBL2 | |
| Interaction | MTHFSD interactions | 4.63e-05 | 10 | 21 | 2 | int:MTHFSD | |
| Interaction | HIF1A interactions | 7.47e-05 | 441 | 21 | 5 | int:HIF1A | |
| Interaction | PIWIL1 interactions | 1.23e-04 | 16 | 21 | 2 | int:PIWIL1 | |
| Interaction | WTIP interactions | 1.23e-04 | 16 | 21 | 2 | int:WTIP | |
| Interaction | NEDD4 interactions | 2.00e-04 | 544 | 21 | 5 | int:NEDD4 | |
| Interaction | TOPBP1 interactions | 2.35e-04 | 117 | 21 | 3 | int:TOPBP1 | |
| Interaction | HPSE2 interactions | 3.06e-04 | 25 | 21 | 2 | int:HPSE2 | |
| Interaction | CREBBP interactions | 3.13e-04 | 599 | 21 | 5 | int:CREBBP | |
| Cytoband | 22q11.21 | 1.18e-03 | 111 | 21 | 2 | 22q11.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q11 | 1.56e-02 | 419 | 21 | 2 | chr22q11 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.38e-03 | 718 | 9 | 3 | 28 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#1_top-relative-expression-ranked_100 | 6.11e-05 | 12 | 21 | 2 | gudmap_developingKidney_e15.5_Cap mesenchyme_100_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#1_top-relative-expression-ranked_100 | 8.42e-05 | 14 | 21 | 2 | gudmap_developingKidney_e15.5_Peripheral blastema_100_k1 | |
| CoexpressionAtlas | Mesoderm Day 5-method_retro_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 9.58e-05 | 91 | 21 | 3 | PCBC_ratio_MESO-5_from-retro_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 9.58e-05 | 91 | 21 | 3 | PCBC_ratio_MESO-5_from-OSKM_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#1_top-relative-expression-ranked_500 | 1.68e-04 | 110 | 21 | 3 | gudmap_developingKidney_e15.5_Podocyte cells_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.87e-04 | 114 | 21 | 3 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#4_top-relative-expression-ranked_100 | 2.33e-04 | 23 | 21 | 2 | gudmap_developingKidney_e15.5_Podocyte cells_100_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.01e-04 | 134 | 21 | 3 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#1_top-relative-expression-ranked_200 | 3.22e-04 | 27 | 21 | 2 | gudmap_developingKidney_e15.5_Peripheral blastema_200_k1 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_500 | 3.47e-04 | 28 | 21 | 2 | gudmap_kidney_P2_CapMes_Crym_k4_500 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 4.26e-04 | 31 | 21 | 2 | gudmap_kidney_P1_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#4_top-relative-expression-ranked_200 | 4.26e-04 | 31 | 21 | 2 | gudmap_developingKidney_e15.5_Cap mesenchyme_200_k4 | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 1.57e-06 | 185 | 21 | 4 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.77e-05 | 22 | 21 | 2 | e345c8c639ca1935b2e2c32533cc8e30819acfeb | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.29e-05 | 157 | 21 | 3 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | wk_20-22-Epithelial-Airway_epithelial_progenitor-epi-stalk_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.25e-05 | 166 | 21 | 3 | b60954e5625743657d0fd9264b738b46e72fd8a6 | |
| ToppCell | wk_20-22-Epithelial-Airway_epithelial_progenitor|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.25e-05 | 166 | 21 | 3 | fcd0bd70b553789092249806ace324b77bd10481 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.47e-05 | 168 | 21 | 3 | 6521bead9789d626b86cbd08692c621c5a5aef33 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.59e-05 | 169 | 21 | 3 | c3ee781735a9288ce1822b230d39bb91c1415589 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 172 | 21 | 3 | 073a503dc922e3e3ac3528e249b0f8b74402110b | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.31e-05 | 175 | 21 | 3 | 43be63976da5ad0764d24d90919a77ce46068f52 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal-GABAergic_neurons|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 7.31e-05 | 175 | 21 | 3 | d4ff1f197ad4086286e86817cbff24fa718293fc | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.56e-05 | 177 | 21 | 3 | 75cb2067a3f2d1b5a964890b02b604d1e79bd163 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Cycling_definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.89e-05 | 187 | 21 | 3 | c0965293f08d3e49000871777a5b26d81a4af203 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.03e-05 | 188 | 21 | 3 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.76e-05 | 193 | 21 | 3 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Mesothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.05e-04 | 198 | 21 | 3 | 86736f01e61bf4961f060b24ee1f1f48340737dd | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-04 | 199 | 21 | 3 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal-Basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-04 | 199 | 21 | 3 | e9c47f565a0a7737ecff68569d668aeb707ae5a6 | |
| ToppCell | Influenza|World / Disease, condition lineage and cell class | 1.08e-04 | 200 | 21 | 3 | df996c35907a1c9194b9e2ca30e81f520ca067f0 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-03 | 104 | 21 | 2 | a4ae3cae44aac8b6e0d14896f9acab44f0cc97c4 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.34e-03 | 116 | 21 | 2 | f32f7eddfe33adb3b5cf7c34667a481a305c5163 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_mature_2|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.70e-03 | 131 | 21 | 2 | f2eee150f5cff852e8f52f09b35e26f17d80833b | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.70e-03 | 131 | 21 | 2 | 537a79ea2b5d6b3dc0444570b1acbceda59b0d7c | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma-6|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.73e-03 | 132 | 21 | 2 | 79b3443c5cfefa172164625a7b2be469311ba2a8 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Slco2a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.76e-03 | 133 | 21 | 2 | 9d7a08170d38ae9b2ff10a0fa505aeb3aae2824d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.83e-03 | 136 | 21 | 2 | 94eb78a4b8da307c07c2c4f05b8a14424f887579 | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.97e-03 | 141 | 21 | 2 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | COVID-19-Fibroblasts-Mesothelial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.97e-03 | 141 | 21 | 2 | 7e6dcccb74e7ee90b69dc91b59491b84f3a713c9 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-03 | 141 | 21 | 2 | d7d3c3932651d90fa4f3c4e3df16f4b677faaf9f | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-03 | 141 | 21 | 2 | 31e0984f09983e83a814424f74c871c1c5a3a789 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasmablast|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.97e-03 | 141 | 21 | 2 | 16b96e9f90231e84b5150b5c239599b3dc28b768 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-03 | 143 | 21 | 2 | 4d11d53330a9197275a8851e1bbf55a113715a09 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-03 | 143 | 21 | 2 | 8b9f4d87d5faac7752c83e1992491fc5550600f8 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.02e-03 | 143 | 21 | 2 | 28e936c298a45f88d14f0146caf3d5a22d483cd5 | |
| ToppCell | E15.5-Hematopoietic-Erythroid-enucleate_erythrocyte|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.02e-03 | 143 | 21 | 2 | e4207ff9e8248813356631631bbf31a63f23ad3c | |
| ToppCell | E15.5-Hematopoietic-Erythroid|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.02e-03 | 143 | 21 | 2 | 15a7b93c381ef0f455f99f3abf4b2b9454d35bc4 | |
| ToppCell | P03-Hematopoietic-Erythroid-enucleate_erythrocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.05e-03 | 144 | 21 | 2 | 9fa63904389f4d7163db22ea85ab721d8f6e8d99 | |
| ToppCell | P03-Hematopoietic-Erythroid|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.05e-03 | 144 | 21 | 2 | 2ee6a834860eac7ed004f366ab4fc38c4b80c905 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-03 | 146 | 21 | 2 | ed932d43e9efd064ee4b49ddef529f3d041be765 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.11e-03 | 146 | 21 | 2 | 03a6a442f1f6d173a41aeebbfe41ee08853d9585 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-03 | 146 | 21 | 2 | 0d74962779055c774312d59fc3b1365163741c3a | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.17e-03 | 148 | 21 | 2 | 223d6a640f3c34e73646a615593b9c0b4a4cbd6f | |
| ToppCell | E12.5-Hematopoietic-Erythroid|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.20e-03 | 149 | 21 | 2 | 08e7f76b7e4b53ff734d50dbc853ecfdeb4b371b | |
| ToppCell | E12.5-Hematopoietic-Erythroid-enucleate_erythrocyte|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.20e-03 | 149 | 21 | 2 | fb75c1b91b8a0c8221fbbc350666799727b21120 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.22e-03 | 150 | 21 | 2 | aa11579a57d671a55e64183d35c1340fda6dec14 | |
| ToppCell | facs-Trachea-nan-24m-Myeloid-granulocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-03 | 151 | 21 | 2 | 26fd55efb647c41436416d45952ee97b050e632c | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.28e-03 | 152 | 21 | 2 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-leukocyte-proliferating_myeloid_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.31e-03 | 153 | 21 | 2 | 596bb7cfd1c713708ce73df30d890a0233eae7f7 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-03 | 153 | 21 | 2 | 82b77c8bae49dd63b8f10eb67df66ca71d0bb315 | |
| ToppCell | PBMC-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 2.31e-03 | 153 | 21 | 2 | db1a6914f2033fb0748e0523cffe5d6dc4e901be | |
| ToppCell | Enthrocyte|World / shred on cell class and cell subclass (v4) | 2.31e-03 | 153 | 21 | 2 | 105b91f5277d145f7717307d7eb9b7d8e8e23576 | |
| ToppCell | Adult-Epithelial-basal_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.31e-03 | 153 | 21 | 2 | 9ee3e7f3f19a2474283c1c79045269686f35a541 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-leukocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.31e-03 | 153 | 21 | 2 | 8cc2667213bfac37545bb63181e88ef1f1834413 | |
| ToppCell | Enthrocyte|World / shred on cell class and cell subclass (v4) | 2.31e-03 | 153 | 21 | 2 | 654265f3c14344071b2af7ca05cbdbb17ce2c5d3 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.34e-03 | 154 | 21 | 2 | 874b1220337276489a89fcc9a39bc81ba6b68baf | |
| ToppCell | Adult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.34e-03 | 154 | 21 | 2 | 38d346402417960044ae999e61f0092b46f2b591 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Granulocytic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-03 | 154 | 21 | 2 | f92d83c5f8b532fe5624f1cd352632f543d96ea9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-03 | 155 | 21 | 2 | e7f49e2fdaf184fa6b4e685518004e7deff1316d | |
| ToppCell | Basal_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.37e-03 | 155 | 21 | 2 | 30accc72a6a914ae0c4d52b373ea1c9a98efbf22 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-03 | 155 | 21 | 2 | 5a872ca70ae8c30b57f45a6772d7bf565e0c2663 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-03 | 155 | 21 | 2 | 77ae0b8d30bc3db4a73fd5340f99691a73d2684f | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Papillary_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.37e-03 | 155 | 21 | 2 | 57259549d7ad97d9f628b821417be5ddac7dbff7 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.40e-03 | 156 | 21 | 2 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-03 | 156 | 21 | 2 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-03 | 156 | 21 | 2 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-03 | 156 | 21 | 2 | ea9223bb6450b22df11efa1705ab72dab005244a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-03 | 156 | 21 | 2 | 586b5509074c4cc359e9e31a968c2ded71c994ca | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.40e-03 | 156 | 21 | 2 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Hsd11b1_Endou|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.46e-03 | 158 | 21 | 2 | c8af8964a140acb2987e3b4906d72c546108d229 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.46e-03 | 158 | 21 | 2 | d78e7e52657dc094430291fec07e9c298be9e584 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.46e-03 | 158 | 21 | 2 | 98712ed7e8e65e8c5ff9318cf0e0a04e271a055d | |
| ToppCell | Basal_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.46e-03 | 158 | 21 | 2 | dd069a822e9698e6dddc155d9a5b52383f7879d5 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-03 | 158 | 21 | 2 | bd37d567754b660bfff7aef81cb307a384ec20a0 | |
| ToppCell | Posterior_cortex|World / BrainAtlas - Mouse McCarroll V32 | 2.49e-03 | 159 | 21 | 2 | 18e9fe2efbe0bca7c3990f3b12b6f549e2c1263a | |
| ToppCell | facs-Lung-EPCAM-18m-Hematologic-leukocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-03 | 160 | 21 | 2 | e6191240c93da34fc4431a35ef496edf323cb41e | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-03 | 160 | 21 | 2 | 9f24ee4fe1ba4590dce5dd4d43707fb007dca82f | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-03 | 160 | 21 | 2 | 3b3b99305558f5b49d050fb9b249007630ea9085 | |
| ToppCell | facs-Lung-EPCAM-18m-Hematologic-Proliferating_Immune|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-03 | 160 | 21 | 2 | 7217730ae14840b935b3bf9aa49becbcbcd8a682 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-03 | 160 | 21 | 2 | 822adcf5f9208f305cafffd8ed97f3a061e82b03 | |
| ToppCell | facs-Lung-EPCAM-18m-Hematologic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-03 | 160 | 21 | 2 | 317ef81460c1a31b51119a6309b11be6a8d4ea3e | |
| ToppCell | facs-Marrow-T-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-03 | 161 | 21 | 2 | 79a4a81963c92ade5b6910816a440dc3c233ead2 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.56e-03 | 161 | 21 | 2 | 78cc5bc488bc47726195a649946d414e6bfabf94 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-HMOX1+_primitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.56e-03 | 161 | 21 | 2 | 6079de6cc4f2aec4091d0fac531fda9a441a70b1 | |
| ToppCell | facs-Marrow-T-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-03 | 161 | 21 | 2 | 1ce40a6d0f0b9870e7ddb3d607668adcbd3dd1d3 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.56e-03 | 161 | 21 | 2 | f50e91f8363f20bb7c565aaca4d4961d3fe4b5b5 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-hematologic-erythrocytic-erythrocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.59e-03 | 162 | 21 | 2 | 25a11e4c6304324310b33a33331ebc812d045d4a | |
| ToppCell | 15-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class | 2.59e-03 | 162 | 21 | 2 | e190c496ed1e206b86566edfee23c99a99fe90d0 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.59e-03 | 162 | 21 | 2 | 0fa93efc9c005d1e649b3f7069ae8641d6e41ed8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.62e-03 | 163 | 21 | 2 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-03 | 163 | 21 | 2 | abec4389cd88252449f110fe95416d67424b403a | |
| ToppCell | 11.5-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 2.62e-03 | 163 | 21 | 2 | 31b60e065bac4ad380247964e7574f210106ebae | |
| ToppCell | 11.5-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 2.62e-03 | 163 | 21 | 2 | e9d814952d824539ff1dea119e4fca14a8c335a8 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-03 | 163 | 21 | 2 | 1eec7f5e5fed05fa21d3f81db588f10605f08ea7 | |
| ToppCell | facs-Marrow-T-cells-24m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-03 | 163 | 21 | 2 | c1e9c3b05d407b4dff1cd53de688b43b61128ad0 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.62e-03 | 163 | 21 | 2 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | Frontal_cortex|World / BrainAtlas - Mouse McCarroll V32 | 2.65e-03 | 164 | 21 | 2 | e09291711abf8680e78170328313719092b0142f | |
| ToppCell | Basal_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.65e-03 | 164 | 21 | 2 | 85487a303194f5244956ec1ca2d1758d38117f41 | |
| ToppCell | droplet-Fat-Gat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-03 | 164 | 21 | 2 | c7ad946829c655038b33748dddd7d68c15489034 | |
| ToppCell | droplet-Fat-Gat-18m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-03 | 164 | 21 | 2 | 3aae702a23fbf1d36a6f18596c23e985581de815 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.68e-03 | 165 | 21 | 2 | d8b0a9b6f704b98e8f0412c11739879a26c036e2 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l26|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.68e-03 | 165 | 21 | 2 | 23955e3373660f827518e723ac62fba99753f375 | |
| Drug | hedamycin | 3.30e-06 | 32 | 21 | 3 | CID000098033 | |
| Drug | Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 2.79e-05 | 195 | 21 | 4 | 3860_UP | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; PC3; HT_HG-U133A | 2.90e-05 | 197 | 21 | 4 | 3727_UP | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; HL60; HG-U133A | 3.02e-05 | 199 | 21 | 4 | 1364_DN | |
| Disease | testicular cancer (implicated_via_orthology) | 4.36e-06 | 5 | 20 | 2 | DOID:2998 (implicated_via_orthology) | |
| Disease | Lung Neoplasms | 2.75e-05 | 265 | 20 | 4 | C0024121 | |
| Disease | Malignant neoplasm of lung | 2.79e-05 | 266 | 20 | 4 | C0242379 | |
| Disease | nephroblastoma (is_implicated_in) | 3.95e-05 | 14 | 20 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | Myeloid Leukemia, Chronic | 1.75e-04 | 29 | 20 | 2 | C0023473 | |
| Disease | cervix uteri carcinoma in situ (is_marker_for) | 3.70e-04 | 42 | 20 | 2 | DOID:8991 (is_marker_for) | |
| Disease | renal cell carcinoma (is_implicated_in) | 9.96e-04 | 69 | 20 | 2 | DOID:4450 (is_implicated_in) | |
| Disease | lung cancer (is_implicated_in) | 1.14e-03 | 74 | 20 | 2 | DOID:1324 (is_implicated_in) | |
| Disease | Pancreatic Neoplasm | 2.08e-03 | 100 | 20 | 2 | C0030297 | |
| Disease | Malignant neoplasm of pancreas | 2.16e-03 | 102 | 20 | 2 | C0346647 | |
| Disease | urinary bladder cancer (is_marker_for) | 2.37e-03 | 107 | 20 | 2 | DOID:11054 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CPPPPPVSTISCSYE | 236 | Q01518 | |
| PSKTVPPHYPVVCCP | 141 | O75618 | |
| PPHYPVVCCPTSGPQ | 146 | O75618 | |
| CPPFSLFTPHQCPEP | 1026 | Q9Y4B6 | |
| PSPGYPLVCVTPCDP | 3186 | Q86XX4 | |
| PPTSCPQCPSTSPAY | 296 | O75593 | |
| APAPPCHALPPLYSC | 486 | Q96FN5 | |
| TPPHERPYACPVESC | 331 | P18146 | |
| EAPCYVSHPSPVPPS | 851 | O15534 | |
| SQPKPCPPEVTPHYI | 26 | Q8N8J0 | |
| YPIPPCRPHATIAPS | 201 | Q86XN7 | |
| CTPPPPYHADPSLVS | 481 | O15350 | |
| HCTPPPPYPTDCSIV | 536 | Q9H3D4 | |
| LITCCAPQPPPPITY | 46 | Q6UX52 | |
| PYLTPCVTCPVPTQS | 931 | O14981 | |
| CICPSLPYSPVSSPQ | 121 | Q96RR4 | |
| PCPLLPSYHCPGVPS | 41 | Q96KS0 | |
| YLGPPPPTTYCPCSI | 56 | Q16621 | |
| PPTTYCPCSIHPDSG | 61 | Q16621 | |
| GCLVPSPPPPYTTSH | 186 | A0PJX4 | |
| SQPKPCPPEVTPHYI | 26 | A4QPH2 | |
| HAPTRPYPCPDCPKS | 141 | Q86XF7 | |
| PYPCPHCPKAFSFPS | 176 | Q86XF7 | |
| PPPVYGCHTPTDSCT | 196 | P19544 |